| |
|
08.16.09 TimelessWealth.net issues technical trade
alert on The Quigley Corporation, stock symbol QGLY ($1.70);
update on Wireless Age Communications, Inc., stock symbol WLSA.pk
($0.149).
Dear Subscriber,
TimelessWealth.net has issued a trading idea with The Quigley
Corp, stock symbol: QGLY ($1.70). The Quigley Corp is in an
oversold condition after losing 75% of its market value since late
April, following a 52-week high ($6.70). On Thursday's trading
session, it hit a new 52-week low ($1.58). The doji candle
representing Friday's trading session is a signal of potential
reversal and will seek Monday's trading session to confirm it.
Annotated chart.
The
Quigley Corporation is organized into three business segments:
cold remedy, contract manufacturing, and ethical pharmaceutical.
The majority of Quigley Corp.'s revenues have come from the
Company's cold remedy segment.
Source The Company's principal cold-remedy product, Cold-EEZE (http://www.cold-eeze.com),
a zinc gluconate glycine formulation (ZIGG™) is an
over-the-counter consumer product used to reduce the duration and
severity of the common cold. The tablet form of the product is
manufactured by
Quigley Manufacturing, Inc. ("QMI"), a wholly owned subsidiary
of the Company.
As
of August 14th, 2009, The Quigley Corp. had 12,991,883 shares
issued and outstanding. Based on $9,216,569 in cash and
equivalents, the cash to share ratio derives nearly 3:4. The cash
flow surplus will allow for the company to engage in various
investing activities as well as finance further research and
development of potential prescription medicines.
Source According to
finance yahoo and
shortsqueeze.com, the float exists just under 7M.
Ted
Karkas, is CEO of The Quigley Corp.
Source Mr. Karkus has 25 years of Wall Street experience and
since 1996 has been providing management consulting services to
emerging-growth companies, including the structuring and raising
of working capital as well as assisting management in developing
operational, marketing and financial strategies. Mr. Karkus was
instrumental in assisting the turnaround of ID Biomedical, an
influenza vaccine manufacturer, which in 2005
was sold to GalaxoSmithKline for over $1.4 billion.
In
reference to our undervalued investment idea, John Simmonds,
Chairman and CEO Wireless Age Communications, Inc., commented on
the upcoming name change that would better reflect the company's
business in the renewable energy sector. We anticipate the name
change to be announced this week, prior to the company revealing a
major waste-to-energy project based in the United States. As
Simmonds stated, "the Connecticut project could potentially create
enough value to qualify Wireless Age Communications, Inc. for
listing on a higher exchange (referencing the American Stock
Exchange and NASDAQ). We encourage you to review our due diligence
series available on our website, under "previous newsletters". We
continue to further our research to deliver transparency and an
intelligent point of view regarding this undervalued investment
opportunity. Please continue to look for our subsequent
newsletters and due diligence titled, "TimelessWealth.net features
due diligence material on undervalued investment: WLSA (Part #)".
All the best.
Sincerely,
Edward Stevenson.
TimelessWealth.net Staff.
 Join Us 
|
|
